SCHEMBL32810

SCHEMBL32810

c1cnc(-n2cccn2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 3/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
G6PD P11413 1/20 0.46
KMT2A Q03164 1/20 0.46
ADORA2A P29274 10/20 0.46
HTT P42858 2/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
NOTUM Q6P988 1/20 0.45
MAPK1 P28482 3/20 0.41
NPC1 O15118 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TDO2 P48775 1/20 0.39
PDE10A Q9Y233 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1706958 0.83 KDM4E (0.47) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL28870957 0.81 HTT (0.62) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL17476686 0.81 KDM4E (0.48) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL28328153 0.80 NOTUM (0.52) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL27992065 0.80 ADORA2A (0.47) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL2898655 0.80 ADORA2A (0.47) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL18218832 0.80 ALDH1A1 (0.44) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL23242476 0.78 HTT (0.50) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL3404328 0.77 ALDH1A1 (0.46) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL9520789 0.77 KDM4E (0.50) KDM4EALDH1A1LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024214568-A1 WATER-BASED COSMETIC 株式会社 資生堂 2024-10-17 WO claimed
CN-118234469-A Composition and method for producing the same 株式会社资生堂 2024-06-21 CN claimed
CN-117835973-A Coating type body correction film forming agent 株式会社资生堂 2024-04-05 CN claimed
CN-117835966-A Method for promoting skin penetration of water-soluble pharmaceutical agent 株式会社资生堂 2024-04-05 CN claimed
US-20220359824-A1 PEROVSKITE SEMICONDUCTOR DEVICES CAMBRIDGE ENTERPRISE LIMITED (GB) 2022-11-10 US claimed
CN-109535142-B 2- (1-pyrazolyl) pyrimidine derivative and preparation method and application thereof 西华大学 2022-01-14 CN claimed
CN-109535142-A 2- (1- pyrazolyl) pyrimidine derivatives and its preparation method and application 西华大学 2019-03-29 CN claimed
CN-104327126-B Pyrimidyl ruthenium copper heteronuclear compounds, and preparation method and application thereof 洛阳师范学院 2017-02-22 CN claimed
CN-104327126-A Pyrimidyl ruthenium copper heteronuclear compounds, and preparation method and application thereof UNIV LUOYANG NORMAL 2015-02-04 CN claimed
EP-2527341-B1 Process for preparation of pyrimidinylpyrazole compounds SHISEIDO CO LTD (JP) 2014-06-18 EP claimed
CN-102712627-B Process for producing pyrimidinylpyrazole compound SHISEDO CO LTD 2013-12-18 CN claimed
US-8592582-B2 Method for producing pyrimidinylpyrazole compounds SHISEIDO COMPANY, LTD. (JP) 2013-11-26 US claimed
US-20120283441-A1 Method For Producing Pyrimidinylpyrazole Compounds SHISEIDO COMPANY, LTD. (JP) 2012-11-08 US claimed
CN-102712627-A Process for producing pyrimidinylpyrazole compound SHISEIDO CO LTD 2012-10-03 CN claimed
CN-101965176-B Skin whitening agent and external preparation for skin SHISEDO CO LTD 2012-06-20 CN claimed
CN-101965176-A Skin whitening agent and external preparation for skin SHISEIDO CO LTD 2011-02-02 CN claimed
JP-63039875-A None JP disclosed
EP-4067350-B1 FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND METHOD FOR MANUFACTURING SAME UNIMATEC CO LTD (JP) 2026-01-07 EP disclosed
US-3723433-A PYRIMIDINYLPYRAZOLE DERIVATIVES AND METHODS FOR PREPARING THE SAME DAIICHI SEIYAKU CO 1973-03-27 US disclosed
JP-S06339875-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283441-A1 Method For Producing Pyrimidinylpyrazole Compounds DCK, IFNG, QDPR KDM4E 1907/4885ALDH1A1 926/4885LMNA 4623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.